- Home
- DGX vs FDS Comparison
DGX vs FDS Comparison
Compare DGX & FDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGX
- FDS
- Stock Information
- Founded
- DGX 1967
- FDS 1978
- Country
- DGX United States
- FDS United States
- Employees
- DGX N/A
- FDS N/A
- Industry
- DGX Medical Specialities
- FDS Computer Software: Programming Data Processing
- Sector
- DGX Health Care
- FDS Technology
- Exchange
- DGX Nasdaq
- FDS Nasdaq
- Market Cap
- DGX 19.2B
- FDS 17.5B
- IPO Year
- DGX 1996
- FDS 1996
- Fundamental
- Price
- DGX $175.90
- FDS $448.67
- Analyst Decision
- DGX Buy
- FDS Sell
- Analyst Count
- DGX 14
- FDS 9
- Target Price
- DGX $185.07
- FDS $443.44
- AVG Volume (30 Days)
- DGX 1.4M
- FDS 242.1K
- Earning Date
- DGX 04-22-2025
- FDS 06-20-2025
- Dividend Yield
- DGX 1.82%
- FDS 0.98%
- EPS Growth
- DGX 6.41
- FDS 11.45
- EPS
- DGX 7.91
- FDS 14.08
- Revenue
- DGX $10,158,000,000.00
- FDS $2,254,222,000.00
- Revenue This Year
- DGX $10.28
- FDS $6.03
- Revenue Next Year
- DGX $4.05
- FDS $5.86
- P/E Ratio
- DGX $22.24
- FDS $31.86
- Revenue Growth
- DGX 9.38
- FDS 4.66
- 52 Week Low
- DGX $135.47
- FDS $391.69
- 52 Week High
- DGX $179.32
- FDS $499.87
- Technical
- Relative Strength Index (RSI)
- DGX 57.57
- FDS 60.43
- Support Level
- DGX $175.25
- FDS $424.99
- Resistance Level
- DGX $179.32
- FDS $437.99
- Average True Range (ATR)
- DGX 3.80
- FDS 9.33
- MACD
- DGX 0.30
- FDS 2.78
- Stochastic Oscillator
- DGX 82.28
- FDS 90.64
About DGX Quest Diagnostics Incorporated
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
About FDS FactSet Research Systems Inc.
FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for 82% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.